Circulating osteoprotegerin and soluble receptor activator of nuclear factor κB ligand in polycystic ovary syndrome: relationships to insulin resistance and endothelial dysfunction

Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society

(2010) Robert A. Wild et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Association of serum osteoprotegerin with ankle-brachial index and urine albumin: Creatinine ratio in African-Americans and non-Hispanic whites

(2009) Zeenat Ali et al.   ATHEROSCLEROSIS

Correlates of increased lean muscle mass in women with polycystic ovary syndrome

(2009) E Carmina et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Comparison of Simvastatin and Metformin in Treatment of Polycystic Ovary Syndrome: Prospective Randomized Trial

(2009) Beata Banaszewska et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Human Full-Length Osteoprotegerin Induces the Proliferation of Rodent Vascular Smooth Muscle Cells both in vitro and in vivo

(2009) Riccardo Candido et al.   JOURNAL OF VASCULAR RESEARCH

Osteoprotegerin in relation to type 2 diabetes mellitus and the metabolic syndrome in postmenopausal women

(2009) Iraj Nabipour et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Comparison between several insulin sensitivity indices and metabolic risk factors in overweight and obese postmenopausal women: A MONET study

(2009) F.M. Malita et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Changes in endothelial function and its association with plasma osteoprotegerin in hypothyroidism with exercise-induced silent myocardial ischaemia

(2008) Xiang Guang-da et al.   CLINICAL ENDOCRINOLOGY

Relationship of elevated osteoprotegerin with insulin resistance, CRP, and TNF-α levels in men with type 2 diabetes

(2008) Subhashini Yaturu et al.   CYTOKINE

Plasma osteoprotegerin levels predict cardiovascular and all-cause mortality and deterioration of kidney function in type 1 diabetic patients with nephropathy

(2008) A. Jorsal et al.   DIABETOLOGIA

The capability of plasma osteoprotegerin as a predictor of cardiovascular disease: a systematic literature review

(2008) Mads Nybo et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Osteoprotegerin in relation to body weight, lipid parameters insulin sensitivity, adipocytokines, and C-reactive protein in obese and non-obese young individuals: results from both cross-sectional and interventional study

(2008) Marie-Hélène Gannagé-Yared et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Serum osteoprotegerin concentrations are decreased in women with the polycystic ovary syndrome

(2008) Héctor F Escobar-Morreale et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

The evaluation of endothelial function with flow-mediated dilatation and carotid intima media thickness in young nonobese polycystic ovary syndrom patients; existence of insulin resistance alone may not represent an adequate condition for deterioration of endothelial function

(2008) Senay Arikan et al.   FERTILITY AND STERILITY